Skip to main content
Log in

Avelumab cost effective for advanced urothelial bladder cancer?

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2021 US dollars

Reference

  • Peng Y, et al. Cost-Effectiveness of Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma in the United States Advances in Therapy : 24 Oct 2021. Available from: URL: https://doi.org/10.1007/s12325-021-01950-0

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Avelumab cost effective for advanced urothelial bladder cancer?. PharmacoEcon Outcomes News 890, 3 (2021). https://doi.org/10.1007/s40274-021-08126-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-08126-0

Navigation